CLX vs MGX · P/E 15, rev $7.10B vs rev $25.2M
The Clorox Company (CLX) versus Metagenomi, Inc. Common Stock (MGX) — a side-by-side from cached financials, not a winner call.
The Clorox Company (CLX) is a household & personal products company listed on US.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Latest reported CLX revenue for 2025-06-30 was $7.10B. Net income was $824.0M. CLX currently screens at market cap $10.89B and trailing P/E 14.6.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
CLX currently screens at market cap $10.89B and trailing P/E 14.6. MGX currently screens at market cap $44.4M.
Not investment advice. Open the CLX and MGX stock pages for the full models.
Not investment advice.